Curebase laid off many employees while sunsetting its full-service clinical operations business and refocusing on software.
SourceModern, AI-powered clinical trial software platform.
Public company, workplace, funding, and market signals
Curebase is a San Francisco-based, remote-first AI-native eClinical platform for clinical trials. It unifies ePRO/eCOA, eConsent, EDC, recruitment, participant engagement, and site workflows to help sponsors, CROs, biotech/pharma teams, and research sites launch studies faster and capture cleaner data.
Primary product
AI-native eClinical platform for decentralized and hybrid clinical trials (including ePRO/eCOA, eConsent, EDC, recruitment, and Sitebase site software)
Founded
2017
Headquarters
San Francisco, California, United States
Team size
11-50
Work style
Remote
Industry
Software Development
Sub-industry
Clinical Trial Management Systems / eClinical software
Offices
0 jobs at Curebase
Check back later for new openings
Business model
Stage
Series B
Total raised
$57.6M
Latest round
Series B · May 2022
Latest amount
$40M
Leadership
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Vice President of Engineering and Product
Sherry Jones
Vice President, Quality
Cori Davis
Head of Customer Success
Jon McHenry
Senior Director, Business Development
Davor Glavas
Director of Customer Success
Vice President of Operations & Strategy
Founders
Founder & former CEO
Investors
Mission-driven, fast-moving, compliance-first, and highly site-advocating. Curebase emphasizes building in-house, one code base/one database, reliability, and patient-centered innovation rather than acquisition-led growth.
Work style
Remote
Visa sponsorship
Limited
Compensation
Public job listings show senior engineering compensation around $180K-$240K base salary plus 0.25%-0.40% equity for a remote US role; at least some roles state US citizen/visa only, so sponsorship appears limited.
Benefits
Pricing
Custom quote / demo-based enterprise pricing; modular. Sitebase site tools are free, with optional paid premium modules.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
4.7K
Traffic estimate as of Jul 2026
Curebase laid off many employees while sunsetting its full-service clinical operations business and refocusing on software.
SourceCoverage from Fierce Biotech confirmed the company had let go of an undetermined number of employees in a pivot away from decentralized and hybrid clinical trials toward software products.
SourceClinical Research News Online · Jan 2026
Curebase said it expanded its AI-native eClinical platform and launched Sitebase, including free CTMS, eISF, and eSource tools for research sites, and highlighted its AI voice agent Hope.
Curebase · Jul 2025
Official company update welcoming Patrick Austermann as VP of Engineering and Product, Grant Rheingold as Head of AI, Joshua Munk as Senior Product Manager, and Zachary Fabiano as Customer Success Manager.
Curebase · Apr 2025
Tom Lemberg stepped back as CEO and Storm Stillman became CEO; the company described the transition as a new chapter focused on continued innovation and growth.
Endpoints News · Aug 2023
Reported layoffs and a strategic pivot away from clinical operations toward software and SaaS partnerships.
Freenome · Jun 2023
Walgreens and Freenome said they would work with Curebase to recruit diverse patients for Freenome's Sanderson Study using Curebase's platform.